Tympanogen

About:

Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.

Website: http://www.tympanogen.com

Top Investors: Virginia Venture Partners, MassChallenge, ShockVentures, NO/LA Angel Network, Virginia Catalyst

Description:

Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.

Total Funding Amount:

$3.29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Richmond, Virginia, United States

Founded Date:

2014-01-01

Founders:

Elaine Horn-Ranney, Jesse Ranney, Parastoo Khoshakhlagh

Number of Employees:

1-10

Last Funding Date:

2022-04-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai